Agreement enhances Companyβs intellectual property portfolio SARASOTA, FL, July 16, 2024 (GLOBE NEWSWIRE...
Extensive Issued and Pending IP Patent Applications Acquired with License Agreement SARASOTA, FL, July 08...
Amplify Bio to complete GLP study of SPC-15 Novel Intranasal Therapeutic Silo study advances SPC-15 towards...
Analytical testing has confirmed optimal formulation for upcoming studies SARASOTA, FL, June 07, 2024 (GLOBE...
SARASOTA, FL, June 06, 2024 (GLOBE NEWSWIRE) -- SARASOTA, FL, June 6, 2024 (GLOBE NEWSWIRE) -- Silo Pharma...
SARASOTA, FL, June 05, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (βSiloβ or the βCompanyβ), a...
Clinical roadmap unveiled for novel and proprietary intranasal PTSD treatment SARASOTA, FL, June 04, 2024...
The study has identified a potentially new drug formulation that could potentially extend the period of...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.